Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Ovarian Neoplasms × TroVax × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Renal Cell 4 Prostatic Neoplasms 2 Recurrence 1 Ovarian Neoplasms 1 Neoplasms 1 Neoplasm Metastasis 1 Kidney Neoplasms 1 Fallopian Tube Neoplasms 1 Colorectal Neoplasms 1

Interventions

Carboplatin 176 Paclitaxel 175 Bevacizumab 71 Topotecan 55 liposomal doxorubicin 54 Gemcitabine 53 Cisplatin 46 Docetaxel 38 Cyclophosphamide 37 olaparib 31 Filgrastim 31 pembrolizumab 26 Doxorubicin 26 niraparib 23 Taxes 23 Drug Therapy 23 Peripheral Blood Stem Cell Transplantation 20 Etoposide 17 veliparib 15 Nivolumab 14 sargramostim 13 Surveys and Questionnaires 13 Immunoglobulin G 13 Disulfides 13 pazopanib 12 Ifosfamide 12 Albumin-Bound Paclitaxel 12 durvalumab 11 atezolizumab 11 Trabectedin 11

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01556841 2019-05-09

TRIOC

University College, London

Phase 2 Completed

Fallopian Tube Neoplasms, Ovarian Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡